Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth
+28.46%
3Y annualised
-1.25% 1D
NAV: 29 May '26
₹44.93
Min. for SIP
₹100
Fund size (AUM)
₹6,668.95 Cr
Expense ratio
1.18%
Rating
5
Return calculator
Monthly investment
₹5,000
| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 6 months | ₹30,000 | ₹32,185 | +7.28% | |
| 1 year | ₹60,000 | ₹64,156 | +6.93% | |
| 3 years | ₹1,80,000 | ₹2,34,437 | +30.24% | |
| 5 years | ₹3,00,000 | ₹4,97,875 | +65.96% |
Holdings (41)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.76% |
| Cipla Ltd | Healthcare | Equity | 8.15% |
| Mankind Pharma Ltd. | Healthcare | Equity | 7.58% |
| Divi's Laboratories Ltd | Healthcare | Equity | 6.06% |
| Dr. Reddy's Laboratories Ltd | Healthcare | Equity | 5.94% |
| Biocon Ltd | Healthcare | Equity | 5.81% |
| Suven Pharmaceuticals Ltd | Healthcare | Equity | 4.44% |
| Lupin Ltd | Healthcare | Equity | 3.80% |
| Medplus Health Services Ltd | Healthcare | Equity | 3.37% |
| Alkem Laboratories Ltd | Healthcare | Equity | 3.24% |
| Syngene International Ltd | Healthcare | Equity | 3.09% |
| Repo | Unspecified | Repo | 2.19% |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | Equity | 2.02% |
| Pfizer Ltd | Healthcare | Equity | 1.96% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 1.93% |
| Abbott India Ltd | Healthcare | Equity | 1.88% |
| Thyrocare Technologies Ltd | Healthcare | Equity | 1.88% |
| JB Chemicals & Pharmaceuticals Ltd | Healthcare | Equity | 1.77% |
| Alembic Pharmaceuticals Ltd | Healthcare | Equity | 1.74% |
| Glenmark Life Sciences Ltd | Healthcare | Equity | 1.72% |
| Entero Healthcare Solutions Ltd. | Healthcare | Equity | 1.72% |
| Gland Pharma Ltd | Healthcare | Equity | 1.51% |
| Blue Jet Healthcare Ltd. | Healthcare | Equity | 1.44% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 1.36% |
| Metropolis Healthcare Ltd | Healthcare | Equity | 1.31% |
| Medi Assist Healthcare Services Ltd. | Industrials | Equity | 1.25% |
| Fine Organic Industries Ltd | Materials | Equity | 1.15% |
| Hikal Ltd | Healthcare | Equity | 1.14% |
| Windlas Biotech Ltd | Healthcare | Equity | 1.10% |
| Net Current Assets | Unspecified | Net Current Assets | 1.05% |
| Aarti Drugs Ltd | Healthcare | Equity | 1.04% |
| Sanofi Consumer Healthcare India Ltd | Healthcare | Equity | 1.03% |
| Anthem Biosciences Ltd. | Healthcare | Equity | 0.90% |
| Astrazeneca Pharma India Ltd | Healthcare | Equity | 0.72% |
| FDC Ltd | Healthcare | Equity | 0.66% |
| Laxmi Dental Ltd. | Healthcare | Equity | 0.66% |
| Shilpa Medicare Ltd | Healthcare | Equity | 0.61% |
| Nephrocare Health Services Ltd. | Healthcare | Equity | 0.42% |
| Sun Pharma Advanced Research Company Ltd | Healthcare | Equity | 0.38% |
| Senores Pharmaceuticals Ltd. | Healthcare | Equity | 0.21% |
| Cash Margin | Unspecified | Cash Margin | 0.01% |
See All
Minimum investments
Min. for 1st investment
₹5,000
Min. for 2nd investment
₹1,000
Min. for SIP
₹100
Returns and rankings
Annualised returns
Absolute returns
| Name | 1Y | 3Y | 5Y | All |
|---|---|---|---|---|
| Fund returns | +8.3% | +28.5% | +16.8% | +21.0% |
| Category average (Equity Sectoral) | -2.1% | +22.1% | +14.6% | -- |
| Rank (Equity Sectoral) | 17 | 1 | 1 | -- |
Exit load, stamp duty and tax
Exit load
Exit load of 1% if redeemed within 15 days.
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data
Fund management
SDSharmila D'SilvaJul 2022 - PresentView details
SD
Sharmila D'Silva
Jul 2022 - Present
View details
DKDharmesh KakkadMay 2020 - PresentView details
DK
Dharmesh Kakkad
May 2020 - Present
View details
About ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is a Equity Mutual Fund Scheme launched by ICICI Prudential Mutual Fund. This scheme was made available to investors on 12 Oct 1993. Sharmila D'Silva is the Current Fund Manager of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹11,12,891 Cr and the Latest NAV as of 29 May 2026 is ₹44.93.
The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹5,000. Exit load of 1% if redeemed within 15 days.
;
Investment Objective
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Fund benchmarkBSE Healthcare Total Return Index
Fund house
Rank (total assets)#3 in India
Total AUM₹11,12,891.15 Cr
Date of Incorporation12 Oct 1993
Launch Date12 Oct 1993
AddressOne BKC , A Wing ,13th Floor, Bandra Kurla Complex, Mumbai 400051
Websitewww.camsonline.com
Address7th Floor, Tower II, Rayala Towers, 158, Anna Salai,